IBS Flashcards

1
Q

epidemiology of IBS

A

young age <45
female
family hx
mental health problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe IBS

A

most common functional GI disorder (FGID)

mixed group of abdominal symptoms for at least 6 months where no organic cause can be found

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

symptoms of IBS

A
abnormal stool frequency 
abnormal stool form
abnormal stool passage 
passing of mucus
bloating or feeling of abdominal distension 
includes non-intestinal symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

non-intestinal symptoms of IBS

A
gynaecological
urinary
back pain 
headaches
bad breath 
poor sleeping 
fatigue 
fibromyalgia
temperomandibular joint dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

gynaecological symptoms of IBS

A

dysmenorrhoea
dyspareunia
premenstrual tension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

urinary symptoms of IBS

A

frequency
urgency
nocturia
incomplete emptying of bladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

biopsychosocial conceptualisation of pathogenesis and clinical expression of FGID

A
disorders of intestinal motility or enhanced visceral perception via;
early life (genetics and environment)
physiology (motility and sensation)
psychological factors (life events, psychological state)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

triggers of IBS

A
GI infection/malabsorption/travel
antibiotic therapy 
pelvic surgery 
psychological stress and trauma 
mood disturbances - anxiety and depression 
food intolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

diagnosing criteria for IBS

A

Rome II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe Rome II

A

in last 12 months there should be at east 12 consecutive weeks of abdominal discomfort with 2/3;
relieved by defecation
onset associated with change in frequency of stool
onset associated with change in form of stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is meant by abnormal stool frequency

A

<3 a week

>3 a day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is meant by abnormal stool form

A

lumpy/hard

loose/watery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is meant by abnormal stool passage

A

striating
urgency
feeling of incomplete evacuation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

red flags for IBS

A

rectal bleeding
nocturnal pain
fever
weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

management for IBS - constipation

A

targeting central and end-organ therapies
5-HT4 receptos agonists
selective C-2 chloride channel activators
guanylatel cyclase agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

end organ treatment for IBS

A

explore dietary triggers
high fibre diet (for constipation)
anti-diarrhoea drugs for bowel frequency
smooth muscle relaxants for pain

17
Q

central treatment for IBS

A
physiological explanation and symptoms 
psychotherapy 
hypnotherapy 
cognitive behavioural therapy
antidepressants
18
Q

anti-diarrhoea drugs

A

loperamide
codeine phosphate
co-phenotrope

19
Q

smooth muscle relaxants drugs

A

mebeverine hydrochloride
dicycloverine hydrochloride
alverine citrate
peppermint oil

20
Q

antidepressants in IBS

A

nortriptyline - diarrhoea

paroxetine - constipation

21
Q

criteria for examining stool

A

bristol stool chart

22
Q

tests for IBS

A

stool culture

upper GI endoscopy

23
Q

5-HT4 receptor agonists

A

prucalopride

24
Q

5-HT4 mechanisms of action

A

stimulates enteric nervous system
increases peristalsis
alleged analgesic effect

25
management of IBS - diarrhoea
targeting central and end-organ therapies | 5-HT3 receptor antagonists
26
selective C-2 chloride channel activators
lubiprostone
27
selective C-2 chloride channel activators mechanisms of action
bicyclic fatty acid derived from prostaglandin E chloride-rich secretion soften stool, increase motility and promote SBMs
28
guanylate cyclase agonist
linaclotide
29
guanylate cyclase agonist mechanisms of action
peptide agonist of guanylate cyclase 2C increases intracellular cyclic GMP increased intestinal secretion and transit reduces abdominal pain
30
loperamide mechanisms of action
reduces stool frequency | improves consistency
31
describe codeine phosphate
effective but should be avoided (patient becomes dependent)
32
5-HT3 receptor antagonists
alosetron
33
5-HT3 receptor antagonists mechanisms of action
improved stool form reduced frequency and less bloating reduced pain